Anteris Technologies Global Corp. (AVR) — Stock Valuation & Research

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These…

AVR key statistics

Price$5.69
Market cap$554.54M
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range3.3-11.06
Beta0.73

Explore AVR's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.